[1] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志,2000,8(6):324-329. [2] HUI CK,LAU GK. Immune system and hepatitis B virus infection[J]. J Clin Virol,2005,34(Suppl 1):44-48. [3] FRANZESE O,KENNEDY PT,GEHRING AJ,et al. Modulation of the CD8 + -T-cell response by CD4 + CD25 + regulatory T cells in patients with hepatitis B virus infection[J]. J Virol,2005,79(6):3322-3328. [4] STOOP JN,VAN DER MOLEN RG,BAAN CC,et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[J]. Hepatology,2005,41(4):771-778. [5] PENG G,LI S,WU W,et al. Circulating CD4 + CD25 + regulatory T cells correlate with chronic hepatitis B infection[J]. Immunology,2008,123(1):57-65. [6] YANG Z,WANG S,ZHANG J,et al. Expression of PD-1 is up-regulated in CD4 + CD25 + FoxP3 + regulatory T cell of non-responders after hepatitis B surface antigen vaccine immunization[J]. Clin Immunol,2008,129(1):176-177. [7] FRANCESCHINI D,PAROLI M,FRANCAVILLA V,et al. PD-L1 negatively regulates CD4 + CD25 + Foxp3 + Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV[J]. J Clin Invest,2009,119(3):551-564. [8] WANG F,WAN L,ZHANG C,et al. Tim-3-Galectin-9 pathway involves the suppression induced by CD4 + CD25 + regulatory T cells[J]. Immunobiology,2009,214(5):342-349. [9] XU D,FU J,JIN L,et al. Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B[J]. J Immunol,2006,177(1):739-747. [10] 沈俊辉,李宁,范学工. 慢性乙型肝炎患者CD4 + CD25 + Treg细胞的检测及意义[J]. 世界华人消化杂志,2007,15(26):2790-2795. |